ClinicalTrials.Veeva

Menu

Impact of C-arm CT in Decreased Renal Function Undergoing TACE for Tx of Hepato-Cellular Carcinoma

Stanford University logo

Stanford University

Status

Terminated

Conditions

Kidney (Renal Cell) Cancer

Treatments

Device: dTA/dBA C-arm fluoroscopy system with Dyna CT
Procedure: CO2 aortogram
Procedure: DSA arteriogram- hepatic arteries

Study type

Observational

Funder types

Other

Identifiers

NCT01326390
SU-07012010-6469 (Other Identifier)
HEP0035

Details and patient eligibility

About

Impact on contrast dose or total volume of contrast required to effectively treat the targeted tumor.

Enrollment

13 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Patients must be affected by HCC
  2. Patients must have diminished renal function (GFR<60 ml/min/1.73m^2)
  3. Patients must be 18 years old or older
  4. Patients must have received an abdominal CT, PET/CT scan or MRI, completed prior to the TACE procedure.
  5. Ability to understand and the willingness to sign a written informed consent document.

Exclusion criteria

  1. Subjects under the age of 18
  2. Patients currently on dialysis
  3. Pregnant women

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems